XML 52 R37.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes (Tables)
12 Months Ended
Dec. 28, 2020
Income Tax Disclosure [Abstract]  
Components of (Loss) Income from Continuing Operations Before Income Taxes

The components of (loss) income from continuing operations before income taxes for the years ended December 28, 2020, December 30, 2019 and December 31, 2018 are:

 

 

For the Year Ended

 

 

 

December 28,

2020

 

 

December 30,

2019

 

 

December 31,

2018

 

 

 

(In thousands)

 

United States

 

$

(84,582

)

 

$

16,066

 

 

$

18,991

 

Foreign

 

 

38,305

 

 

 

18,260

 

 

 

28,194

 

(Loss) income from continuing operations before income taxes

 

$

(46,277

)

 

$

34,326

 

 

$

47,185

 

Components of Income Tax Benefit (Provision)

The components of income tax benefit (provision) for the years ended December 28, 2020, December 30, 2019 and
December 31, 2018 are:

 

 

For the Year Ended

 

 

 

December 28,

2020

 

 

December 30,

2019

 

 

December 31,

2018

 

 

 

(In thousands)

 

Current benefit (provision):

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(44

)

 

$

294

 

 

$

381

 

State

 

 

(4,624

)

 

 

(2,922

)

 

 

(1,294

)

Foreign

 

 

27,902

 

 

 

(12,748

)

 

 

(9,587

)

Total current

 

 

23,234

 

 

 

(15,376

)

 

 

(10,500

)

Deferred benefit (provision):

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

2,446

 

 

 

1,004

 

 

 

97,723

 

State

 

 

4,498

 

 

 

(1,076

)

 

 

14,351

 

Foreign

 

 

(287

)

 

 

13,043

 

 

 

(13,367

)

Total deferred

 

 

6,657

 

 

 

12,971

 

 

 

98,707

 

Income tax benefit (provision)

 

$

29,891

 

 

$

(2,405

)

 

$

88,207

 

Reconciliation of Provision for Income Taxes at Statutory Federal Income Tax Rate Compared to Provision for Income Taxes

The following is a reconciliation of the provision for income taxes at the statutory federal income tax rate compared to the Company’s provision for income taxes for the years ended December 28, 2020, December 30, 2019 and December 31, 2018:

 

 

For the Year Ended

 

 

 

December 28,

2020

 

 

December 30,

2019

 

 

December 31,

2018

 

 

 

(In thousands)

 

Statutory federal income tax benefit (provision)

 

$

9,718

 

 

$

(7,209

)

 

$

(9,909

)

State income taxes, net of federal benefit and state tax credits

 

 

(2,674

)

 

 

(3,163

)

 

 

(1,953

)

Transfer pricing

 

 

 

 

 

 

 

 

1,483

 

Acquisition related expenses

 

 

 

 

 

 

 

 

(1,737

)

IRC Section 162(m) limitation

 

 

(712

)

 

 

(868

)

 

 

(3,702

)

Stock options

 

 

(1,298

)

 

 

(252

)

 

 

1,072

 

Global Intangible Low-Taxed Income

 

 

(1,300

)

 

 

 

 

 

 

Permanently reinvested earnings assertion

 

 

(1,442

)

 

 

(1,765

)

 

 

(14,313

)

Foreign tax differential on foreign earnings & other permanent items

 

 

3,933

 

 

 

687

 

 

 

(3,685

)

Change in valuation allowance

 

 

(2,668

)

 

 

2,127

 

 

 

118,451

 

Uncertain tax positions

 

 

36,936

 

 

 

999

 

 

 

(954

)

Federal research and development credits

 

 

4,250

 

 

 

4,582

 

 

 

2,996

 

Goodwill impairment

 

 

(14,532

)

 

 

 

 

 

 

Other

 

 

(320

)

 

 

2,457

 

 

 

458

 

Income tax benefit (provision)

 

$

29,891

 

 

$

(2,405

)

 

$

88,207

 

Significant Components of Net Deferred Income Tax Assets and Liabilities The significant components of the net deferred income tax assets (liabilities) as of December 28, 2020 and December 30, 2019 are as follows:

 

 

 

As of

 

 

 

December 28,

2020

 

 

December 30,

2019

 

 

 

(In thousands)

 

Deferred income tax assets:

 

 

 

 

 

 

 

 

Net operating loss carryforwards

 

$

43,209

 

 

$

78,774

 

Reserves and accruals

 

 

29,429

 

 

 

24,765

 

Interest expense limitation

 

 

 

 

 

13,102

 

Unrealized loss on cash flow hedge

 

 

4,713

 

 

 

2,960

 

Tax credit carryforwards

 

 

39,757

 

 

 

37,889

 

Stock-based compensation

 

 

4,216

 

 

 

4,440

 

Original issue discount on Convertible Senior Notes

 

 

90

 

 

 

870

 

Property, plant and equipment

 

 

9,989

 

 

 

14,404

 

Other deferred income tax assets

 

 

403

 

 

 

756

 

 

 

 

131,806

 

 

 

177,960

 

Less: valuation allowance

 

 

(15,322

)

 

 

(14,292

)

 

 

 

116,484

 

 

 

163,668

 

Deferred income tax liabilities:

 

 

 

 

 

 

 

 

Repatriation of foreign earnings

 

 

(4,006

)

 

 

(9,691

)

Property, plant and equipment basis differences

 

 

(50,463

)

 

 

(56,476

)

Goodwill and intangible amortization

 

 

(39,668

)

 

 

(73,263

)

Other deferred income tax liabilities

 

 

(5,700

)

 

 

(102

)

Net deferred income tax assets (included in

      Deposits and other non-current assets)

 

$

16,647

 

 

$

24,136

 

 

 

Summary of Activity in Valuation Allowance

The following summarizes the activity in the Company’s valuation allowance for the years ended December 28, 2020, December 30, 2019 and December 31, 2018:

 

 

For the Year Ended

 

 

 

December 28,

2020

 

 

December 30,

2019

 

 

December 31,

2018

 

 

 

(In thousands)

 

Balance at beginning of year

 

$

14,292

 

 

$

16,635

 

 

$

152,728

 

Reduction related to acquisition

 

 

 

 

 

 

 

 

(76,040

)

Additions charged to expense

 

 

3,904

 

 

 

1,526

 

 

 

 

Other reduction charged to expense

 

 

(2,874

)

 

 

(3,869

)

 

 

(60,053

)

Balance at end of year

 

$

15,322

 

 

$

14,292

 

 

$

16,635

 

Summary of HNTE and R&D Benefit and Effect on Earnings per Share The HNTE status as well as enhanced research and development (R&D) deductions decreased Chinese taxes. HNTE and R&D benefit and effect on earnings per share are as follows:

 

 

 

For the Year Ended

 

 

 

December 28,

2020

 

 

December 30,

2019

 

 

December 31,

2018

 

 

 

(In thousands, except per share data)

 

HNTE and R&D benefits

 

$

4,235

 

 

$

6,060

 

 

$

7,277

 

Basic shares

 

 

106,366

 

 

 

105,195

 

 

 

103,355

 

Diluted shares

 

 

106,366

 

 

 

106,332

 

 

 

134,036

 

Increases earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.04

 

 

$

0.06

 

 

$

0.07

 

Diluted

 

$

0.04

 

 

$

0.06

 

 

$

0.05

 

 

Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits

A reconciliation of the beginning and ending amount of unrecognized tax benefits, exclusive of accrued interest and penalties, is as follows:

 

 

For the Year Ended

 

 

 

December 28,

2020

 

 

December 30,

2019

 

 

December 31,

2018

 

 

 

(In thousands)

 

Balance at beginning of year

 

$

37,465

 

 

$

30,284

 

 

$

31,276

 

Additions related to acquisition

 

 

 

 

 

 

 

 

903

 

Additions based on tax positions related to the current year

 

 

839

 

 

 

3,553

 

 

 

856

 

Additions for tax positions of prior years

 

 

202

 

 

 

4,952

 

 

 

117

 

Reductions for tax positions of prior years

 

 

(27,283

)

 

 

(103

)

 

 

(2,140

)

Lapse of statute of limitations

 

 

(3,819

)

 

 

(1,221

)

 

 

(728

)

Balance at end of year

 

$

7,404

 

 

$

37,465

 

 

$

30,284